ASSURE WCD Clinical Evaluation - Detection and Safety Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT03887052

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Kestra Medical Technologies, Inc. (from the registry)
Registry
  • NCT NCT03887052
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03887052. Allocation not applicable; no masking; primary purpose other. Start 2019-03-20 (actual); primary completion 2019-06-18 (actual). Results posted on 2023-10-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ASSURE WCD Clinical Evaluation - Detection and Safety Study
Acronym
ACE-DETECT
Condition
Cardiac Arrest, Sudden
Intervention (Device)
ASSURE™ Wearable Cardioverter Defibrillator (WCD)
Lead sponsor
Kestra Medical Technologies, Inc. (class: industry)
Collaborator
Regulatory and Clinical Research Institute Inc (class: other)

Record details

Record id
cardio:ct-nct03887052
Content hash
ae5d0bddbcb63741b053a0324d6a2f990c88d37dcb3ca70e633eb76da4056fd7